Ubs Group Ag Beyond Spring Inc. Transaction History

Ubs Group Ag

$528 Billion
Q1 2025

A detailed history of Ubs Group Ag transactions in Beyond Spring Inc. stock. As of the latest transaction made, Ubs Group Ag holds 40,881 shares of BYSI stock, worth $100,567. This represents 0.0% of its overall portfolio holdings.

Number of Shares

40,881

Previous 58,091 29.63%

Holding current value

$100,567

Previous $94,000 38.3%

% of portfolio

0.0%

Previous 0.0%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 13, 2025	SELL	$1.44 - $1.8 $24,782 - $30,978	-17,210 Reduced 29.63%	40,881 $58,000
Q4 2024 Feb 14, 2025	BUY	$1.55 - $2.57 $80,150 - $132,894	51,710 Added 810.37%	58,091 $94,000
Q3 2024 Nov 14, 2024	SELL	$1.74 - $2.47 $18,275 - $25,942	-10,503 Reduced 62.21%	6,381 $14,000
Q2 2024 Aug 13, 2024	BUY	$1.76 - $3.6 $18,217 - $37,263	10,351 Added 158.44%	16,884 $40,000
Q1 2024 May 13, 2024	BUY	$0.85 - $3.63 $5,491 - $23,453	6,461 Added 8973.61%	6,533 $23,000
Q4 2023 Feb 09, 2024	BUY	$0.67 - $1.12 $10 - $16	15 Added 26.32%	72 $0
Q1 2023 May 12, 2023	SELL	$1.06 - $3.05 $6,983 - $20,093	-6,588 Reduced 99.14%	57 $0
Q4 2022 Feb 08, 2023	BUY	$0.56 - $2.61 $3,689 - $17,194	6,588 Added 11557.89%	6,645 $12,000
Q3 2022 Nov 10, 2022	SELL	$0.97 - $1.81 $5,611 - $10,470	-5,785 Reduced 99.02%	57 $0
Q2 2022 Aug 10, 2022	SELL	$1.13 - $2.66 $4,225 - $9,945	-3,739 Reduced 39.03%	5,842 $8,000
Q1 2022 May 16, 2022	SELL	$1.68 - $5.01 $26,827 - $80,004	-15,969 Reduced 62.5%	9,581 $21,000
Q4 2021 Feb 14, 2022	BUY	$4.02 - $16.84 $98,618 - $413,118	24,532 Added 2409.82%	25,550 $116,000
Q3 2021 Nov 15, 2021	BUY	$9.26 - $31.31 $2,916 - $9,862	315 Added 44.81%	1,018 $16,000
Q2 2021 Aug 13, 2021	SELL	$9.37 - $12.12 $49,398 - $63,896	-5,272 Reduced 88.23%	703 $7,000
Q1 2021 May 12, 2021	SELL	$10.61 - $15.77 $19,787 - $29,411	-1,865 Reduced 23.79%	5,975 $66,000
Q4 2020 Feb 11, 2021	BUY	$10.21 - $17.31 $35,132 - $59,563	3,441 Added 78.22%	7,840 $96,000
Q3 2020 Nov 12, 2020	SELL	$9.99 - $16.13 $10,579 - $17,081	-1,059 Reduced 19.4%	4,399 $59,000
Q2 2020 Jul 31, 2020	SELL	$11.21 - $18.15 $34,392 - $55,684	-3,068 Reduced 35.98%	5,458 $82,000
Q1 2020 May 01, 2020	SELL	$9.68 - $18.47 $88,978 - $169,776	-9,192 Reduced 51.88%	8,526 $109,000
Q4 2019 Feb 14, 2020	BUY	$11.83 - $18.68 $93,539 - $147,702	7,907 Added 80.59%	17,718 $275,000
Q3 2019 Nov 14, 2019	BUY	$15.33 - $23.85 $120,785 - $187,914	7,879 Added 407.82%	9,811 $178,000
Q2 2019 Aug 14, 2019	BUY	$13.36 - $23.7 $24,208 - $42,944	1,812 Added 1510.0%	1,932 $46,000
Q1 2019 May 14, 2019	BUY	$16.01 - $19.96 $1,921 - $2,395	120 New	120 $2,000
Q4 2018 Feb 14, 2019	SELL	$17.15 - $26.08 $3,567 - $5,424	-208 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$19.31 - $27.15 $4,016 - $5,647	208 New	208 $5,000
Q1 2018 May 15, 2018	SELL	$20.39 - $33.94 $21,022 - $34,992	-1,031 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$28.45 - $39.47 $4,068 - $5,644	143 Added 16.1%	1,031 $30,000
Q3 2017 Nov 14, 2017	BUY	$35.55 - $41.28 $30,750 - $35,707	865 Added 3760.87%	888 $33,000
Q2 2017 Aug 14, 2017	SELL	N/A	-2,789 Reduced 99.18%	23 $1,000
Q1 2017 Nov 14, 2017	BUY	N/A	2,812	2,812 $56,000

Others Institutions Holding BYSI

# of Institutions

Shares Held

5.28M

Call Options Held

200

Put Options Held

View Full List

About BeyondSpring Inc.

Ticker BYSI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,928,900
Market Cap $95.8M
Description
BeyondSpring Inc., a clinical stage biopharmaceutical company, together with its subsidiaries, focuses on the development of cancer therapies. The company's lead asset is the Plinabulin, a selective immune-modulating microtubule-binding agent that has completed Phase III clinical trials for the prevention of chemotherapy-induced neutropenia; and...

More about BYSI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.

Account